Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 519

1.

Molecular genetic changes in benign colorectal tumors synchronous with microsatellite unstable carcinomas do not support a field defect.

Zauber P, Marotta S, Sabbath-Solitare M.

Int J Mol Epidemiol Genet. 2017 Jun 15;8(3):27-39. eCollection 2017.

2.

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.

Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA, Eknæs M, Lind GE, Myklebost O, Skotheim RI, Sveen A, Lothe RA.

Mol Cancer. 2017 Jul 6;16(1):116. doi: 10.1186/s12943-017-0691-y.

3.

BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis.

Li Y, Li W.

Saudi J Gastroenterol. 2017 May-Jun;23(3):144-149. doi: 10.4103/1319-3767.207712. Review.

4.

Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype.

Williamson JS, Jones HG, Williams N, Griffiths AP, Jenkins G, Beynon J, Harris DA.

World J Gastrointest Oncol. 2017 May 15;9(5):209-217. doi: 10.4251/wjgo.v9.i5.209.

5.

Role of Epigenetics in Uveal Melanoma.

Li Y, Jia R, Ge S.

Int J Biol Sci. 2017 Mar 11;13(4):426-433. doi: 10.7150/ijbs.18331. eCollection 2017. Review.

6.

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.

Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V, Kalogeras KT, Fountzilas G, Grady WM.

Clin Epigenetics. 2017 May 2;9:46. doi: 10.1186/s13148-017-0347-1. eCollection 2017.

7.

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

Yanokura M, Banno K, Adachi M, Aoki D, Abe K.

Int J Oncol. 2017 Jun;50(6):1934-1946. doi: 10.3892/ijo.2017.3966. Epub 2017 Apr 19.

8.

Findings in young adults at colonoscopy from a hospital service database audit.

Wong S, Lidums I, Rosty C, Ruszkiewicz A, Parry S, Win AK, Tomita Y, Vatandoust S, Townsend A, Patel D, Hardingham JE, Roder D, Smith E, Drew P, Marker J, Uylaki W, Hewett P, Worthley DL, Symonds E, Young GP, Price TJ, Young JP.

BMC Gastroenterol. 2017 Apr 19;17(1):56. doi: 10.1186/s12876-017-0612-y.

9.

Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival.

Lee CT, Huang YC, Hung LY, Chow NH, Su PF, Ho CL, Tsai HW, Chen YL, Lin SC, Lin BW, Lin PC, Lee JC.

Oncotarget. 2017 May 23;8(21):35165-35175. doi: 10.18632/oncotarget.16815.

10.

Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.

Romain B, Benbrika-Nehmar R, Marisa L, Legrain M, Lobstein V, Oravecz A, Poidevin L, Bour C, Freund JN, Duluc I, Guenot D, Pencreach E.

Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.

11.

Comprehensive characterization of DNA methylation changes in Fuchs endothelial corneal dystrophy.

Khuc E, Bainer R, Wolf M, Clay SM, Weisenberger DJ, Kemmer J, Weaver VM, Hwang DG, Chan MF.

PLoS One. 2017 Apr 6;12(4):e0175112. doi: 10.1371/journal.pone.0175112. eCollection 2017.

12.

A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer.

Cui G, Liu D, Li W, Fu X, Liang Y, Li Y, Shi W, Chen X, Zhao S.

Medicine (Baltimore). 2017 Apr;96(14):e6552. doi: 10.1097/MD.0000000000006552.

13.

DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.

Takane K, Akagi K, Fukuyo M, Yagi K, Takayama T, Kaneda A.

Cancer Med. 2017 May;6(5):1023-1035. doi: 10.1002/cam4.1061. Epub 2017 Apr 4.

14.

DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.

Liang G, Weisenberger DJ.

Epigenetics. 2017 Jun 3;12(6):416-432. doi: 10.1080/15592294.2017.1311434. Epub 2017 Mar 30. Review.

PMID:
28358281
15.

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.

McInnes T, Zou D, Rao DS, Munro FM, Phillips VL, McCall JL, Black MA, Reeve AE, Guilford PJ.

BMC Cancer. 2017 Mar 28;17(1):228. doi: 10.1186/s12885-017-3226-4.

16.

CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.

Sánchez-Vega F, Gotea V, Chen YC, Elnitski L.

World J Gastrointest Oncol. 2017 Mar 15;9(3):105-120. doi: 10.4251/wjgo.v9.i3.105.

17.

The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.

Savio AJ, Mrkonjic M, Lemire M, Gallinger S, Knight JA, Bapat B.

Clin Epigenetics. 2017 Mar 9;9:26. doi: 10.1186/s13148-017-0326-6. eCollection 2017.

18.

A Clinically Distinct and 'Atypical' Subgroup of Head and Neck Cancers Positive for a CpG Island Methylator Phenotype.

Weisenberger DJ.

EBioMedicine. 2017 Mar;17:22-23. doi: 10.1016/j.ebiom.2017.03.008. Epub 2017 Mar 6. No abstract available.

19.

Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie.

Loree JM, Kopetz S, Raghav KP.

J Gastrointest Oncol. 2017 Feb;8(1):199-212. doi: 10.21037/jgo.2017.01.01. Review.

20.

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.

Bae JM, Kim JH, Kwak Y, Lee DW, Cha Y, Wen X, Lee TH, Cho NY, Jeong SY, Park KJ, Han SW, Lee HS, Kim TY, Kang GH.

Br J Cancer. 2017 Apr 11;116(8):1012-1020. doi: 10.1038/bjc.2017.52. Epub 2017 Mar 9.

Supplemental Content

Support Center